Paracip at a Glance
Paracip 500 mg Cipla is a pharmaceutical-grade acetaminophen preparation manufactured by Cipla Limited for laboratory research applications. Each tablet contains 500 mg of paracetamol (acetaminophen), providing researchers with standardised dosage units for investigating analgesic and antipyretic mechanisms in controlled experimental protocols. The compound is recognised globally as a reference standard for pain management and fever reduction research, making it essential for pharmacological laboratories studying non-opioid analgesic pathways. Researchers at Stroid UK Shop can access this pharmaceutical-grade compound for comprehensive studies examining acetaminophen’s therapeutic mechanisms and comparative efficacy evaluations.
Laboratory Applications
Research scientists investigate Paracip tablets in comparative analgesic studies, examining dose-response relationships and pharmacokinetic profiles across different experimental models. The standardised 500 mg formulation enables precise experimental design for studying acetaminophen’s cyclooxygenase inhibition mechanisms and central nervous system effects. Pharmaceutical researchers examine this compound alongside other anti-inflammatory compounds to evaluate relative efficacy and safety profiles. Laboratory studies commonly investigate acetaminophen’s hepatic metabolism pathways, examining glucuronidation and sulfation conjugation processes. Research applications extend to comparative studies with selective androgen receptor modulators and peptide compounds for understanding multi-modal therapeutic approaches in experimental protocols.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Acetaminophen (Paracetamol) |
| Strength | 500 mg per tablet |
| Manufacturer | Cipla Limited |
| CAS Number | 103-90-2 |
| Molecular Formula | C₈H₉NO₂ |
| Molecular Weight | 151.16 g/mol |
| Storage Conditions | Room temperature, dry conditions |
| Formulation | Oral tablet |
Research Compliance
Paracip 500 mg Cipla tablets are supplied exclusively for in-vitro research and laboratory analytical purposes. This pharmaceutical preparation is intended solely for qualified research institutions conducting studies on analgesic mechanisms, pharmacological pathways, and comparative therapeutic evaluations. Researchers must ensure appropriate laboratory protocols and safety measures when handling this compound. All experimental applications must comply with institutional research guidelines and regulatory requirements governing pharmaceutical research materials.
